Suggested Topics within your search.
Suggested Topics within your search.
Article
1
New York Heart Association class
SGLT-2 inhibitors
1
adult
1
aged
1
amino terminal pro brain natriuretic peptide
1
angiotensin receptor antagonist
1
atrial fibrillation
1
beta adrenergic receptor blocking agent
1
body mass
1
cardiovascular mortality
1
clinical effectiveness
1
clinical feature
1
clinical trials
1
controlled study
1
dapagliflozin
1
dipeptidyl carboxypeptidase inhibitor
1
double blind procedure
1
female
1
heart failure with mildly reduced ejection fraction
1
heart failure with preserved ejection fraction
heart failure with reduced ejection fraction
1
high risk patient
1
hospital admission
1
human
1
major clinical study
1
male
1
medical history
1
mineralocorticoid antagonist
1
non insulin dependent diabetes mellitus
1
-
1by Al Habeeb, W., Alcocer Gamba, M.A, Belohlavek, J., Cabrera Honorio, J.W, Chiang, C.-E, Claggett, B.L, Comin-Colet, J., de Boer, R.A, DeMets, D., Dobreanu, D., Drozdz, J., Fang, J.C, Han, Y., Hernandez, A.F, Inzucchi, S.E, Janssens, S.P, Katova, T., Kerr Saraiva, J.F, Kitakaze, M., Kosiborod, M.N, Lam, C.S.P, Lindholm, D., Martinez, F., McMurray, J.J.V, Merkely, B., O'Meara, E., Petersson, M., Shah, S.J, Solomon, S.D, Tereschenko, S.N, Thierer, J., Vaduganathan, M., Vardeny, O., Verma, S., Vinh, P.N, Wilderäng, U., Willem Borleffs, C.J, Zaozerska, N.Subjects: “...heart failure with preserved ejection fraction...”
Published 2022
View Fulltext in Publisher
Article